Adoption of Global Quality Standards is required for Indian Pharma: OPPI

OPPI stands for the Organisation of Pharmaceutical Producers of India and it represents the research-based pharmaceutical companies in India. It completely engages with the government and other stakeholders to find the best sustainable healthcare solutions.

According to OPPI, Indian pharma required to adopt global quality standards to gain the growth of the sector and bring all stakeholders like regulators, industry, and governments to work jointly towards it.

WHO (World Health Organisation) has set some quality standards like GMP(Good Manufacturing Practices) and Indian pharma should need to maintain uniform baseline with them. Kanchana, OPPI director general said that the medicine making process should follow the global standards and need to implement from initial manufacturing stage to the delivery chain.

To address the quality issues in the pharmaceutical industry, all the government officials, industry representatives, industry associations and patient groups met in the Summit. All were discussed about the gamut of issues covering quality, ranging from labeling to packaging and storage at the summit.

Uttar Pradesh Department of Food Safety and Drug Administration study reports that around 38% of medicines are not effective as they are the outcome of low-quality standards. India has a number of pharmaceutical manufacturing industries but no quality standards maintained across the board.

To raise manufacturing quality standards, the government need to work with industry associations and other stakeholders including patient groups that represent the public and have to work together. That step will keep India globally competitive and Indian drugs sought after in global markets. Challenges like regulatory issues need to be addressed on the urgent basis for the growth of the Indian pharmaceutical industry.

Kanchana also commented on Government policies that policies should be more predictable and should remain for 3-5 years and Pharma Industry is in the need to have progressive policy changes.

OPPI just want to convey the importance of quality in delivering responsible and safe patient care as the quality of the medicine also plays an important role in cure process.

Related Posts

Three arrested after liquor bottles found at pharma firm

Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

Anton Paar India hosted the first day of NEXUS 2026 at Ramada by Wyndham, Navi Mumbai, bringing together leading experts, scientists, researchers and industry professionals from the pharmaceutical sector for…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two

Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two